Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $158.10 | Total: $790.50 |
| 1 | 10 | $133.92 | Total: $1,339.20 |
| 1 | 25 | $113.46 | Total: $2,836.50 |
| 1 | 50 | $96.72 | Total: $4,836.00 |
| 1 | 100 | $83.70 | Total: $8,370.00 |
Overview
ReN-1869 is a novel selective histamine H(1) receptor antagonist with anti-neurogenic pain and anti-inflammatory activity for the study of neurological diseases.
Chemical Properties
| Molecular Formula | C24H27NO2 |
| Molecular Weight | 361.48 |
| CAS Numbers | 170149-99-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CCN1C[C@H](C(O)=O)CCC1)=C2C=3C(CCC=4C2=CC=CC4)=CC=CC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Schaffler K, Seibel K, Thomsen M, Edwards M. Effect of the new H1-antagonist ReN1869 on capsaicin-induced hyperalgesia in human skinHuman phase-I trial using somatosensory evoked potentials induced by a CO2 laser. Arzneimittelforschung. 2004;54[3] 187-91. PubMed PMID 15112866.